Efficacy of Methimazole Dosing Algorithm
NCT05964452 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 11
Last updated 2024-12-27
Summary
To prospectively study the efficacy and safety of the Cook County Health (CCH) methimazole (MMI) dosing algorithm in the setting of new onset Graves' disease.
Conditions
- Graves Disease
Interventions
- DRUG
-
Methimazole Tablets
Testing dosing algorithm for efficacy.
Sponsors & Collaborators
-
Cook County Health
lead OTHER_GOV
Principal Investigators
-
Dan Mihailescu, MD · Cook County Health
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-02-14
- Primary Completion
- 2024-09-17
- Completion
- 2024-09-17
Countries
- United States
Study Locations
More Related Trials
-
Study to Determine the Dose, the Safety and Effectiveness of a New Drug, Modified Release rhTSH, in Patients With Multinodular Goiter
NCT00454220 ·Status: COMPLETED ·Phase: PHASE2
-
The Role of Thyroid Status in Regulating Brown Adipose Tissue Activity, White Adipose Tissue Partitioning and Resting Energy Expenditure
NCT03064542 ·Status: COMPLETED
-
A Clinical Study of Hyperthyroidism in Children
NCT06570967 ·Status: RECRUITING
-
Intervention to Decrease Overtreatment of Patients With Low-risk Thyroid Cancer
NCT06073223 ·Status: COMPLETED ·Phase: NA
-
Measuring Symptom Relief After Radiofrequency Ablation of the Thyroid
NCT05501041 ·Status: ENROLLING_BY_INVITATION
-
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
NCT07018323 ·Status: RECRUITING ·Phase: PHASE2
-
Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease
NCT05461820 ·Status: RECRUITING ·Phase: PHASE4
-
Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid Cancer
NCT04868045 ·Status: WITHDRAWN ·Phase: PHASE1
-
Treatment for Patients With Metastatic Thyroid Cancer
NCT00176748 ·Status: COMPLETED ·Phase: PHASE2
-
Thyroid Replacement Therapy in Patients With Subclinical Hypothyroidism
NCT04953195 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
NCT06727604 ·Status: RECRUITING ·Phase: PHASE2
-
Methimazole in Graves' Disease - Comparing the Computer-aided Treatment DigiThy Versus Usual Care
NCT06327828 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer
NCT00094055 ·Status: COMPLETED ·Phase: PHASE2
-
rhTSH, Radioiodine Uptake and Goiter Reduction Following 131I Therapy in Patients With Benign Nontoxic Nodular Goiter
NCT00275171 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Study of Different I-131 Doses in Graves' Disease
NCT02114619 ·Status: UNKNOWN ·Phase: NA
-
Insulin Sensitivity and Metabolism Before and After Treatment in Patients With Hypothyroidism
NCT00770016 ·Status: TERMINATED ·Phase: NA
-
Change of Gut Microbiome in the Treatment of Graves' Disease
NCT04383795 ·Status: COMPLETED
-
Early Levothyroxine Post Radioactive Iodine
NCT01950260 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Preoperative Corticosteroids in Autoimmune Thyroid Disease
NCT05435547 ·Status: RECRUITING ·Phase: PHASE4
-
A Safety and Tolerability Study of Otelixizumab in Thyroid Eye Disease
NCT01114503 ·Status: TERMINATED ·Phase: PHASE2
-
NOMOTHETICOS: Nonlinear Modelling of Thyroid Hormones' Effect on Thyrotropin Incretion in Confirmed Open-loop Situation
NCT01145040 ·Status: UNKNOWN
-
Metabolomics of Thyroid Hormones
NCT03823859 ·Status: COMPLETED
-
The Effect of Early Total Thyroidectomy in the Course of Graves' Orbitopathy
NCT01056419 ·Status: UNKNOWN ·Phase: PHASE4
-
Intestinal Microbiota and Treatment of GD
NCT03433352 ·Status: UNKNOWN
-
Evaluation of Optimal Time of Methimazole Discontinuation Before Radio-iodine Therapy in Hyperthyroid Grave's Patients
NCT01560299 ·Status: COMPLETED ·Phase: NA